TVM Life Science Ventures VII Announces Investment in AurKa Pharma

News   Sep 20, 2016

 
TVM Life Science Ventures VII Announces Investment in AurKa Pharma
 
 
 

RELATED ARTICLES

Cancer Cells Prevent Immune Cells from Producing Cancer Killing Chemicals

News

Researchers have identified a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages

READ MORE

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

Study Shows Cancer Patients Are Choosing Less Severe Side Effects Over Treatment Efficacy

News

When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a new study.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE